Advertisement
Singapore markets closed

  • Straits Times Index

    3,439.88
    +24.37 (+0.71%)
     

  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     

  • Dow

    39,308.00
    -23.90 (-0.06%)
     

  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     

  • Bitcoin USD

    57,417.16
    -2,797.19 (-4.65%)
     

  • CMC Crypto 200

    1,199.35
    -61.83 (-4.90%)
     

  • FTSE 100

    8,230.79
    +59.67 (+0.73%)
     

  • Gold

    2,369.40
    0.00 (0.00%)
     

  • Crude Oil

    83.80
    -0.08 (-0.10%)
     

  • 10-Yr Bond

    4.3550
    0.0000 (0.00%)
     

  • Nikkei

    40,913.65
    +332.89 (+0.82%)
     

  • Hang Seng

    18,028.28
    +49.71 (+0.28%)
     

  • FTSE Bursa Malaysia

    1,616.75
    +1.43 (+0.09%)
     

  • Jakarta Composite Index

    7,220.89
    +24.13 (+0.34%)
     

  • PSE Index

    6,507.49
    +57.46 (+0.89%)
     

Brazil's Biolab buys Canada's Exzell Pharma

Reuters

SAO PAULO (Reuters) - Brazilian pharmaceutical company Biolab has bought Canadian healthcare business Exzell Pharma, the company said in a statement on Monday.

Biolab's Canadian subsidiary acquired the company, which has sales and marketing infrastructure as well as brands including Swiss Naturals, Salinex, Esoph, and Myoflex.

The deal value was not disclosed. Biolab CEO Cleiton Castro Marques said in the statement the acquisition streghtens the Brazilian company's international activities. Exzell maintains a portfolio focused primarily on gastroenterology, dermatology, vitamins, and supplements.

(Reporting by Tatiana Bautzer; editing by Barbara Lewis)